Twinbeech Capital LP 4 D Molecular Therapeutics, Inc. Transaction History
Twinbeech Capital LP
- $4.99 Billion
- Q3 2024
A detailed history of Twinbeech Capital LP transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 76,310 shares of FDMT stock, worth $594,454. This represents 0.02% of its overall portfolio holdings.
Number of Shares
76,310
Previous 58,619
30.18%
Holding current value
$594,454
Previous $1.23 Million
33.01%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$57.5 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$39.7 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$38.1 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$34.3 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$31.9 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $252M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...